|
1
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Ervik M, Lam F, Colombet M, Mery
L, Piñeros M, Znaor A, Soerjomataram I and Bray F: Global Cancer
Observatory: Cancer Today. International Agency for Research on
Cancer; Lyon: 2020, https://gco.iarc.fr/todayDecember 1–2018
|
|
3
|
Wagner AD, Syn NL, Moehler M, Grothe W,
Yong WP, Tai BC, Ho J and Unverzagt S: Chemotherapy for advanced
gastric cancer. Cochrane Database Syst Rev.
8:CD0040642017.PubMed/NCBI
|
|
4
|
Patel TH and Cecchini M: Targeted
therapies in advanced gastric cancer. Curr Treat Options Oncol.
21:702020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonelli P, Borrelli A, Tuccillo FM,
Silvestro L, Palaia R and Buonaguro FM: Precision medicine in
gastric cancer. World J Gastrointest Oncol. 11:804–829. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lyons K, Le LC, Pham YT, Borron C, Park
JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, et al: Gastric
cancer: Epidemiology, biology, and prevention: A mini review. Eur J
Cancer Prev. 28:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zahir Ahmed S, Cirocchi N, Saxton E and
Brown MK: Incidence of age migration of colorectal cancer in
younger population: Retrospective single centred-population based
cohort study. Ann Med Surg (Lond). 74:1032142021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carleton M, Mao M, Biery M, Warrener P,
Kim S, Buser C, Marshall CG, Fernandes C, Annis J and Linsley PS:
RNA interference-mediated silencing of mitotic kinesin KIF14
disrupts cell cycle progression and induces cytokinesis failure.
Mol Cell Biol. 26:3853–3863. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gruneberg U, Neef R, Li X, Chan EH,
Chalamalasetty RB, Nigg EA and Barr FA: KIF14 and citron kinase act
together to promote efficient cytokinesis. J Cell Biol.
172:363–372. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cullati SN, Kabeche L, Kettenbach AN and
Gerber SA: A bifurcated signaling cascade of NIMA-related kinases
controls distinct kinesins in anaphase. J Cell Biol. 216:2339–2354.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ahmed SM, Thériault BL, Uppalapati M, Chiu
CW, Gallie BL, Sidhu SS and Angers S: KIF14 negatively regulates
Rap1a-Radil signaling during breast cancer progression. J Cell
Biol. 199:951–967. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang W, Shi Y, Li J, Cui W and Yang B:
Up-regulation of KIF14 is a predictor of poor survival and a novel
prognostic biomarker of chemoresistance to paclitaxel treatment in
cervical cancer. Biosci Rep. 36:e003152016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corson TW, Zhu CQ, Lau SK, Shepherd FA,
Tsao MS and Gallie BL: KIF14 messenger RNA expression is
independently prognostic for outcome in lung cancer. Clin Cancer
Res. 13:3229–3234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Y, Yuan Y, Liang P, Zhang Z, Guo X,
Xia L, Zhao Y, Shu XS, Sun S, Ying Y and Cheng Y: Overexpression of
a novel candidate oncogene KIF14 correlates with tumor progression
and poor prognosis in prostate cancer. Oncotarget. 8:45459–45469.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Z, Li C, Yan C, Li J, Yan M, Liu B,
Zhu Z, Wu Y and Gu Q: KIF14 promotes tumor progression and
metastasis and is an independent predictor of poor prognosis in
human gastric cancer. Biochim Biophys Acta Mol Basis Dis.
1865:181–192. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klimaszewska-Wiśniewska A, Neska-Długosz
I, Buchholz K, Durślewicz J, Grzanka D, Kasperska A, Antosik P,
Zabrzyński J, Grzanka A and Gagat M: Prognostic significance of
KIF11 and KIF14 expression in pancreatic adenocarcinoma. Cancers
(Basel). 13:30172021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Huang W, Huang W, Wei T, Zhu W, Chen
G and Zhang J: Kinesin family members KIF2C/4A/10/11/14/18B/20A/23
predict poor prognosis and promote cell proliferation in
hepatocellular carcinoma. Am J Transl Res. 12:1614–1639.
2020.PubMed/NCBI
|
|
19
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Niederle MB, Hackl M, Kaserer K and
Niederle B: Gastroenteropancreatic neuroendocrine tumours: the
current incidence and staging based on the WHO and European
neuroendocrine tumour society classification: An analysis based on
prospectively collected parameters. Endocr Relat Cancer.
17:909–918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang T, Shi W, Tian K and Kong Y:
Chaperonin containing t-complex polypeptide 1 subunit 6A correlates
with lymph node metastasis, abnormal carcinoembryonic antigen and
poor survival profiles in non-small cell lung carcinoma. World J
Surg Oncol. 18:1562020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu H, Jin C, Zhu Q, Liu T, Ke B, Li A and
Zhang T: Dysregulated expressions of PTEN, NF-κB, WWP2, p53 and
c-Myc in different subtypes of B cell lymphoma and reactive
follicular hyperplasia. Am J Transl Res. 11:1092–1101.
2019.PubMed/NCBI
|
|
23
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neska-Długosz I, Buchholz K, Durślewicz J,
Gagat M, Grzanka D, Tojek K and Klimaszewska-Wiśniewska A:
Prognostic impact and functional annotations of KIF11 and KIF14
expression in patients with colorectal cancer. Int J Mol Sci.
22:97322021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao L and Zhang S, Zheng Q and Zhang S:
Dysregulation of KIF14 regulates the cell cycle and predicts poor
prognosis in cervical cancer: A study based on integrated
approaches. Braz J Med Biol Res. 54:e113632021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li KK, Qi Y, Xia T, Chan AK, Zhang ZY,
Aibaidula A, Zhang R, Zhou L, Yao Y and Ng HK: The kinesin KIF14 is
overexpressed in medulloblastoma and downregulation of KIF14
suppressed tumor proliferation and induced apoptosis. Lab Invest.
97:946–961. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Q, Ren H, Li X, Qian B, Fan S, Hu F,
Xu L and Zhai B: Silencing KIF14 reverses acquired resistance to
sorafenib in hepatocellular carcinoma. Aging (Albany NY).
12:22975–23003. 2020.PubMed/NCBI
|
|
28
|
Thériault BL, Cybulska P, Shaw PA, Gallie
BL and Bernardini MQ: The role of KIF14 in patient-derived primary
cultures of high-grade serous ovarian cancer cells. J Ovarian Res.
7:1232014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thériault BL, Pajovic S, Bernardini MQ,
Shaw PA and Gallie BL: Kinesin family member 14: An independent
prognostic marker and potential therapeutic target for ovarian
cancer. Int J Cancer. 130:1844–1854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang ZZ, Yang J, Jiang BH, Di JB, Gao P,
Peng L and Su XQ: KIF14 promotes cell proliferation via activation
of Akt and is directly targeted by miR-200c in colorectal cancer.
Int J Oncol. 53:1939–1952. 2018.PubMed/NCBI
|
|
31
|
Han BA, Yang XP, Hosseini DK, Zhang P,
Zhang Y, Yu JT, Chen S, Zhang F, Zhou T and Sun HY: Identification
of candidate aberrantly methylated and differentially expressed
genes in esophageal squamous cell carcinoma. Sci Rep. 10:97352020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Ma C, Zhang Y, Pei S, Du M, Zhang
Y, Qian L, Wang J, Yin L and He X: MiR-154-5p suppresses cell
invasion and migration through inhibiting KIF14 in nasopharyngeal
carcinoma. Onco Targets Ther. 13:2235–2246. 2020. View Article : Google Scholar : PubMed/NCBI
|
